Pharmaceutical Industry Information Portal

HomeNews

News

GMP-inspections of veterinary manufacturers in the second half of 2021

The review provides information related to the inspection of manufacturers of medicinal products for veterinary use for compliance with the requirements of the Good Manufacturing Practice (GMP).

AstraZeneca and Neurimmune sign exclusive global collaboration to develop and commercialise NI006

Alexion, AstraZeneca’s Rare Disease group, has entered into an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal...

The European Union shared 380 million doses COVID-19 vaccines with low and middle income countries in 2021

The European Union shared 380 million doses to low- and middle-income countries, mostly through COVAX, informed in the Statement by President von der Leyen...

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop mRNA-based Vaccine

Pfizer Inc. and BioNTech SE announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of...

Russia ready to manufacture foreign anti-COVID vaccines, if need be – Denis Manturov, industry minister

It is up to the Health Ministry to decide whether to launch the production of foreign vaccines against the novel coronavirus in Russia for...

WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao Site

WuXi STA – a subsidiary of WuXi AppTec, announced that its Waigaoqiao site in Shanghai, China, successfully passed the first drug product pre-approval inspection...
spot_img

Expert Articles

spot_img